Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2016-02-29
2020-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MotionLoc Study, Femur Fractures
NCT01612208
Plating of Distal Femur Fractures by Far Cortical Locking Using MotionLoc Screws
NCT01667887
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Plates and Screws System
NCT05215613
PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix® Small External Fixation System
NCT05943574
A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System
NCT04015167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Radiographic \& clinical fracture healing at 3 months post-surgery.
Secondary Endpoints:
* Complications
* Radiologic \& clinical fracture healing at 6 weeks, 3, 6, and 12 months post-surgery.
* Callus size \& distribution at 6 weeks, 3, 6, and 12 months post-surgery.
Radiologic fracture healing is defined as bridging of three of the four cortices as seen on x-ray/CT. Clinical healing will be assessed using the Function Index for Trauma (FIX-IT). The FIX-IT instrument quantifies clinical healing by assessing weight-bearing and fracture site pain on an ordinal scale. It has been initially validated in patients with tibia and femur fractures.
Callus size of the anterior, posterior, and medial aspect will be assessed for each time point using a validated and published computational method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group One
Distal Tibia Fracture repaired with Zimmer MotionLoc Screw
Zimmer MotionLoc Screw
Patients with distal tibia fractures (AO 43-A and C) requiring surgical intervention eligible for locked plating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zimmer MotionLoc Screw
Patients with distal tibia fractures (AO 43-A and C) requiring surgical intervention eligible for locked plating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Close or open fractures Gustilo type I
* Unilateral or bilateral fractures
* Patients who are capable of understanding the doctor's explanations, following his instructions and are able to participate in the follow-up program.
* Patients who give written consent to take part in the study by signing the "Patient Consent Form".
Exclusion Criteria
* Open fractures Gustilo type II \& III
* History of infection of the affected extremity
* Non-ambulatory patients
* Planned fixation strategy includes interfragmentary lag screw fixation of non-articular fractures.
* Addition of bone graft, bone graft substitute or bone morphogenetic protein (BMP).
* Immobilization with plaster.
* Likely problems with maintaining follow-up program (e.g. patients with no fixed address, plans to move during course of study)
* Not expected to survive the duration of follow-up program.
* Patients known to be pregnant or breastfeeding.
* Patients who are unwilling or unable to give consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kacy Arnold, RN MBA
Role: STUDY_DIRECTOR
Zimmer Biomet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Springfield Clinic
Springfield, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
Donald B. Slocum Research and Education Foundation
Eugene, Oregon, United States
Mackay Specialist Day Hospital
Mount Pleasant, , Australia
Azienda Ospedaliera Universitaria Senese
Siena, , Italy
Korea University Anam Hospital
Seoul, , South Korea
The Dudley Group NHS Foundation Trust
Dudley, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSE2014-08T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.